Methods of treating fibrosis
The present disclosure is directed in part to methods of treating fibrosis, e.g., hepatic fibrosis and/or intestinal fibrosis, comprising administering to a patient in need thereof an effective amount of a disclosed compound.
1. A method of treating idiopathic pulmonary fibrosis, the method comprising administering to a patient in need thereof, a therapeutically effective amount of 2-methoxy-3-(4′-aminophenyl)-propionic acid,
or a pharmaceutically acceptable salt and/or a stereoisomer thereof.
2. The method of claim 1 , wherein the 2-methoxy-3-(4′-aminophenyl)propionic acid is (S)-2-methoxy-3-(4′-aminophenyl)propionic acid, or a pharmaceutically acceptable salt thereof.
3. The method of claim 1 , wherein the administering is orally.
4. The method of claim 1 , wherein the patient is human.
5. A method of treating idiopathic pulmonary fibrosis, the method comprising administering to a patient in need thereof, a pharmaceutical preparation comprising a therapeutically effective amount of 2-methoxy-3-(4′-aminophenyl)-propionic acid,
or a pharmaceutically acceptable salt and/or a stereoisomer thereof.
6. The method of claim 5 , wherein the pharmaceutical preparation is administered orally.
7. The method of claim 5 , wherein the patient is human.
8. The method of claim 5 , wherein the 2-methoxy-3-(4′-aminophenyl)propionic acid is (S)-2-methoxy-3-(4′-aminophenyl)propionic acid, or a pharmaceutically acceptable salt thereof.